Inventor

LOU YAN

US75 patents

⚠️ This page may combine multiple inventors who share the name “LOU YAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LOU YAN

NIKANG THERAPEUTICS INC

Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors

Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases

Process of preparing 3-fluoro-5(((1R,2aR)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile

Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors

Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof

Process of preparing 3-fluoro-5(((1R,2AR)-3,3,4,4-tetrafluoro-1,2A-dihydroxy-2,2A,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile

NEWAVE PHARMACEUTICAL INC

BCL-2 inhibitors

Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases

BCL-2 inhibitors

Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases

BCL-2 inhibitors

Therapeutic agents for the treatment of HBV infection

Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases

Dual-warhead covalent inhibitors of FGFR-4

Therapeutic agents for the treatment of HBV infection

DEWDNEY NOLAN JAMES

Inhibitors of bruton&#39;s tyrosine kinase

Inhibitors of bruton&#39;s tyrosine kinase

Inhibitors of Bruton&#39;s tyrosine kinase

Inhibitors of bruton&#39;s tyrosine kinase

Inhibitors of Burton&#39;s tyrosine kinase

Inhibitors of bruton&#39;s tyrosine kinase

ROCHE PALO ALTO LLC

Pyrrolopyrazine kinase inhibitors

Inhibitors of bruton&#39;s tyrosine kinase

Inhibitors of Bruton&#39;s tyrosine kinase

Inhibitors of bruton&#39;s tyrosine kinase

Btk protein kinase inhibitors

NOVARTIS AG

Biaryl amide compounds as kinase inhibitors

Biaryl amide compounds as kinase inhibitors

Biaryl amide compounds as kinase inhibitors

Biaryl amide compounds as kinase inhibitors

Compounds and compositions as RAF kinase inhibitors

Roche Palo Alto

Pyrrolopyrazine kinase inhibitors

Pyrrolopyrazine kinase inhibitors

Inhibitors of bruton&#39;s tyrosine kinase

Pyrrolopyrazine kinase inhibitors

PRINCIPIA BIOPHARMA INC

Immunoproteasome inhibitors

Immunoproteasome inhibitors

Immunoproteasome inhibitors

Immunoproteasome inhibitors

NIKANG THERAPUETICS INC

Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors

HOFFMANN LA ROCHE

Inhibitors of bruton&#39;s tyrosine kinase

Inhibitors of Bruton&#39;s tyrosine kinase

BROTHERTON-PLEISS CHRISTINE E

Inhibitors of bruton&#39;S tyrosine kinase

BERTHEL STEVEN

Inhibitors of Bruton&#39;s tyrosine kinase

BERTHEL STEVEN JOSEPH

Inhibitors of bruton&#39;s tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of Bruton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of Burton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of Bruton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase

Inhibitors of Bruton's tyrosine kinase

Inhibitors of bruton'S tyrosine kinase

Inhibitors of Bruton's tyrosine kinase

Inhibitors of bruton's tyrosine kinase